BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  ONO PHARMA USA Announces 2023 Golden Ticket Competition in Partnership with LabCentral and MBC BioLabs

  ONO PHARMA USA announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco, to award each organization one Golden Ticket for an innovative life sciences startup company.

  April 18, 2023

   · 

  4 min read
• Business

  Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2023

  Genmab A/S announced that worldwide net trade sales of DARZALEX®, including sales of the subcutaneous product, as reported by Johnson & Johnson were USD 2,264 million in the first quarter of 2023.

  April 18, 2023

   · 

  3 min read
• Business

  Johnson & Johnson Reports Q1 2023 Results

  Johnson & Johnson announced results for first-quarter 2023.

  April 18, 2023

   · 

  14 min read
• Business

  Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023

  Sage Therapeutics, Inc. announced that it will host a live webcast on Tuesday, May 2, 2023 at 8:00 a.m. ET to review first quarter 2023 financial results and discuss recent business updates.

  April 18, 2023

   · 

  1 min read
• BioCapital

  Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival

  Immunocore Holdings plc has presented four posters with KIMMTRAK data in HLA-A*02:01 patients with metastatic uveal melanoma, at the 2023 American Association for Cancer Research Annual Meeting 2023.

  April 18, 2023

   · 

  12 min read
• Medicenna to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

  Medicenna Therapeutics Corp. today announced that Dr. Fahar Merchant, President and CEO of Medicenna, will participate in a fireside chat and management will participate in one-on-one meetings at the 2023 Bloom Burton & Co. Healthcare Investor Conference.

  April 18, 2023

   · 

  1 min read
• Drug Development

  Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023

  Surface Oncology today announced the presentation of new preclinical data for SRF114, a fully human anti-CCR8 antibody, at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, Florida.

  April 18, 2023

   · 

  3 min read
• Genetown

  Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference

  Sigilon Therapeutics, Inc. today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will present a corporate overview during the Needham Virtual Healthcare Conference.

  April 18, 2023

   · 

  1 min read
• Bio NC

  BioCryst Refinances Existing Debt with $450 Million Financing Commitment from Pharmakon

  BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company has secured $450 million in committed financing from funds managed by Pharmakon Advisors, LP. BioCryst has elected to draw $300 million of the $450 million available to the company on the closing date.

  April 18, 2023

   · 

  4 min read
• Identifai-Genetics Closes a Post-Seed Fundraising Round of USD 3.3M; Dr. Susan Gross, former CMO at Natera, named as Chief Strategic Advisor

  Identifai-Genetics announced today that it has completed a post-seed fundraising round of USD 3.3M.

  April 18, 2023

   · 

  3 min read